methyl nicotinate has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, AI; Glen, EM; Sutherland, J; Ward, PE | 1 |
| Hoffman, WF; Messamore, E; Yao, JK | 1 |
1 trial(s) available for methyl nicotinate and arachidonic acid
| Article | Year |
|---|---|
Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Topics: Adult; Anti-Inflammatory Agents; Arachidonic Acid; Dose-Response Relationship, Drug; Erucic Acids; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Flushing; Humans; Male; Middle Aged; Models, Biological; Niacin; Nicotinic Acids; Regression Analysis; Schizophrenia; Skin; Skin Tests | 2010 |
1 other study(ies) available for methyl nicotinate and arachidonic acid
| Article | Year |
|---|---|
Niacin skin flush in schizophrenia: a preliminary report.
Topics: Adult; Arachidonic Acid; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Erythrocyte Membrane; Feasibility Studies; Female; Flushing; Humans; Male; Middle Aged; Nicotinic Acids; Pilot Projects; Prostaglandin D2; Psychiatric Status Rating Scales; Reference Values; Schizophrenia; Sensitivity and Specificity; Skin; Vasodilation | 1998 |